Branded

Camcevi 42 mg subcutaneous injection is a gonadotropin-releasing hormone agonist indicated for the treatment of adult patients with advanced prostate cancer.

This new approval makes Nurtec ODT the first oral CGRP antagonist approved for the preventive treatment of migraine, and the only migraine medication approved as a dual therapy for both the acute and preventive treatment.

The authorization allows Sotrovimab to be distributed and administered as a 500 mg single dose intravenously by healthcare providers.

Rybrevant is the first treatment for adult patients with non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.

Kloxxado contains twice as much naloxone per spray as Narcan Nasal Spray 4mg in a ready-to-use nasal spray, which is used to reverse the effects of opioid overdose.

Natroba is now approved as a topical treatment for scabies infestations in adult and pediatric patients four years of age and older.

The acquisition expands Pfizer’s anti-infectives pipeline.

Ragwitek now is indicated to treat ragweed pollen allergy in children and adolescents 5-17 years old, in addition to adults as old as 65.